No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control*
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hypoglycemic Agents / therapeutic use
-
PCSK9 Inhibitors
-
Prognosis
-
Risk Factors
Substances
-
Antibodies, Monoclonal
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Hypoglycemic Agents
-
PCSK9 Inhibitors
-
PCSK9 protein, human